Epi Zyme Inc is categorized under Commercial Biotechnical Research in Cambridge, MA and active since 2007.
Epi Zyme Inc was established in 2007, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Robert Gould, Chief Executive Officer at the company’s single location by writing to 400 Technology Square # 4, Cambridge, Massachusetts MA 02139 or by phoning (617) 500-7240. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Epi Zyme Inc |
| Contact Person: | Robert Gould, Chief Executive Officer |
| Address: | 400 Technology Square # 4, Cambridge, Massachusetts 02139 |
| Phone Number: | (617) 500-7240 |
| Website Address: | epizyme.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 3254120 |
| Share This Business: |
Epi Zyme Inc was started in 2007 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Robert Gould, Chief Executive Officer for inquiries that concern Epi Zyme Inc by calling the company number (617) 500-7240, as your correspondence is most welcome. Additionally, the physical location of the single location of Epi Zyme Inc can be found at the coordinates 42.36369,-71.09117 as well as the street address 400 Technology Square # 4 in Cambridge, Massachusetts 02139.
For its online presence, you may visit Epi Zyme Inc’s website at epizyme.com and engage with its social media outlets through on Twitter and on Facebook.